The rise of Viagra initially drove a surge for major pharmaceutical companies, but recent shifts present a murky scenario for those considering a stake. Generic alternatives are eating into profits, and persistent https://alberttuit153433.blogaritma.com/39071102/sildenafil-and-pharma-a-risky-investment